The immune system and cancer

Area of Science:

• Immunology
• Oncology
• Cancer Research

Background:

• Adaptive immune responses are mounted by cancer patients against tumors.
• Tumor-infiltrating lymphocytes (TILs) and natural killer (NK) cells attempt to eliminate malignant cells.
• Malignant cells develop mechanisms to evade immune detection and destruction.

Purpose of the Study:

• To elucidate the multifaceted mechanisms by which cancer cells evade host immunosurveillance.
• To understand how tumor cells subvert anti-tumor immune responses.

Main Methods:

• Analysis of immunosuppressive factors produced by malignant cells (cytokines, prostaglandins).
• Evaluation of mechanisms of immune resistance, including antigen processing and presentation.
• Investigation of T-cell elimination strategies employed by tumor cells (activation-induced cell death, Fas ligand expression).

Main Results:

• Malignant cells secrete immunosuppressive cytokines and prostaglandins, promoting a Th2-biased immune response with reduced anti-tumor capacity.
• Selection of tumor variants with altered Major Histocompatibility Complex (MHC) class I and II expression and impaired antigen processing reduces tumor antigenicity.
• Tumor cells actively induce T-cell death via activation-induced cell death or Fas ligand-mediated counterattack.

Conclusions:

• Cancer cells employ a combination of immunosuppression, immune resistance, and active T-cell elimination to evade immunosurveillance.
• Understanding these evasion mechanisms is crucial for developing effective cancer immunotherapies.